Table 1 Baseline characteristics of patients in the two outcome groups
Variable | Total | Favorable outcome group (n = 42, 58.3%) | Unfavorable outcome group (n = 30, 41.7%) | P value |
|---|---|---|---|---|
Age (years), mean ± SD | 64.8 ± 10.9 | 64.5 ± 11.8 | 65.1 ± 9.8 | 0.820 |
Male, n (%) | 45 (62.5) | 27 (64.3) | 18 (60.0) | 0.711 |
Hypertension, n (%) | 48 (66.7) | 28 (66.7) | 20 (66.7) | 1.000 |
Diabetes mellitus, n (%) | 23 (31.9) | 17 (40.5) | 6 (20.0) | 0.066 |
Coronary heart disease, n (%) | 21 (29.2) | 12 (28.6) | 9 (30.0) | 0.895 |
Atrial fibrillation, n (%) | 24 (33.3) | 16 (31.8) | 8 (26.7) | 0.310 |
Previous history of cerebrovascular disease, n (%) | 10 (13.9) | 5 (11.9) | 5 (16.7) | 0.565 |
Previous antiplatelet therapy, n (%) | 14 (19.4) | 9 (21.4) | 5 (16.7) | 0.615 |
Current smoker, n (%) | 34 (47.2) | 21 (50.0) | 13 (43.3) | 0.576 |
NIHSS score at admission, median (IQR) | 14 (9–19) | 13 (8–17) | 17 (12–20) | 0.015a |
Glucose level at admission (mg/dL), mean ± SD | 152.3 ± 85.0 | 163.8 ± 108.0 | 135.0 ± 30.6 | 0.157 |
SBP level at admission (mmHg), mean ± SD | 153.8 ± 23.5 | 146.9 ± 18.5 | 163.5 ± 25.5 | 0.003a |
DBP level at admission (mmHg), mean ± SD | 85.2 ± 13.4 | 83.4 ± 12.8 | 87.6 ± 14.0 | 0.189 |
LDL-C at admission (mg/dL), median (IQR) | 44.73 (34.97–55.71) | 45.18 (34.43–53.15) | 44.01 (35.19–57.60) | 0.541 |
TOAST type, n (%) | ||||
Large artery atherosclerosis | 44 (61.1) | 23 (54.8) | 21 (70.0) | 0.442 |
Cardioembolism | 23 (31.9) | 16 (38.1) | 7 (23.3) | |
Clear reason | 4 (5.6) | 2 (4.8) | 2 (6.7) | |
Unknown reason | 1 (1.4) | 1 (2.4) | 0 (0.0) | |
ASPECTS at admission, median (IQR) | 8 (7–9) | 8 (8-9) | 7 (6.75–8) | < 0.001a |
Vascular lesion | ||||
M1 of the middle cerebral artery | 51 (70.8) | 35 (83.3) | 16 (53.3) | 0.006a |
Internal carotid artery | 21 (29.2) | 7 (16.7) | 14 (46.7) | |
Type of anesthesia | ||||
General anesthesia, n (%) | 9 (12.5) | 4 (9.5) | 5 (16.7) | 0.366 |
Conscious sedation, n (%) | 63 (87.5) | 38 (90.5) | 25 (83.3) | 0.366 |
Time from stroke onset to groin puncture (min), mean ± SD | 290.5 ± 80.5 | 297.0 ± 72.5 | 281.4 ± 91.1 | 0.421 |
Type of endovascular treatment | ||||
Combined intravenous thrombolysis and thrombectomy, n (%) | 19 (26.4) | 8 (19.0) | 11 (36.7) | 0.094 |
Intra-arterial thrombolysis, n (%) | 10 (13.9) | 9 (21.4) | 1 (3.3) | 0.029a |
Direct mechanical thrombectomy, n (%) | 43 (59.7) | 25 (59.5) | 18 (60.0) | 0.968 |
Frequency of mechanical thrombectomy, median (IQR) | 2 (2–3) | 2 (1–3) | 3 (2–3) | 0.024a |
Rates of successful recanalization, n (%) | 62 (86.1) | 40 (95.2) | 22 (73.3) | 0.008a |
Intracranial haemorrhagic transformation, n (%) | ||||
HI1 | 5 (6.9) | 4 (9.5) | 1 (3.3) | 0.197 |
HI2 | 5 (6.9) | 2 (4.8) | 3 (10.0) | |
PH1 | 2 (2.8) | 0 (0.0) | 2 (6.7) | |
PH2 | 1 (1.4) | 0 (0.0) | 1 (3.3) | |